Cargando…
Evaluation of Ischemia-Modified Albumin and C-Reactive Protein in Type 2 Diabetics With and Without Ketosis
OVERVIEW: To investigate whether serum ischemia-modified albumin or C-reactive protein is reliable for predicting type 2 diabetic patients with ketosis. APPROACH: One hundred and four diabetic patients, 48 with diabetic ketosis, and 33 controls were enrolled in the study. Serum ischemia-modified alb...
Autores principales: | Ma, Shao-gang, Jin, Yao, Hu, Wen, Bai, Feng, Xu, Wen, Yu, Wei-nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308681/ https://www.ncbi.nlm.nih.gov/pubmed/22442627 http://dx.doi.org/10.4137/BMI.S9060 |
Ejemplares similares
-
Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease
por: Shao-gang,, et al.
Publicado: (2011) -
Ketosis-Onset Diabetes and Ketosis-Prone Diabetes: Same or Not?
por: Liu, Beiyan, et al.
Publicado: (2013) -
The Role of Ischemia-modified Albumin and Ischemia-Modified Albumin to Albumin Ratios in Patients with Alopecia Areata
por: Tanacan, Efsun, et al.
Publicado: (2023) -
Association between Serum Albumin Concentration and Ketosis Risk in Hospitalized Individuals with Type 2 Diabetes Mellitus
por: Cheng, Po-Chung, et al.
Publicado: (2016) -
Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels
por: Yang, Liu-Xue, et al.
Publicado: (2013)